These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Effects of different beta-receptor antagonists on handgrip in essential hypertension. Fogari R; Marchesi E; Bellomo G; Parini A; Corradi L Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):551-3. PubMed ID: 6129200 [TBL] [Abstract][Full Text] [Related]
48. [Evaluation of 6-years' use of beta blocking agents in the treatment of arterial hypertension in pregnancy (143 case reports recorded between May 1976 and December 1982)]. Monnier JC; Valat AS; Lanciaux B; Dognin C LARC Med; 1984 Feb; 4(2):61-6. PubMed ID: 6144020 [No Abstract] [Full Text] [Related]
49. A comparison of nifedipine with methyldopa in pregnancy induced hypertension. Jayawardana J; Lekamge N Ceylon Med J; 1994 Jun; 39(2):87-90. PubMed ID: 7923458 [TBL] [Abstract][Full Text] [Related]
50. [Beta-blockaders in the treatment of hypertension in pregnancy]. Kawecka-Jaszcz K; Skoczeń M Kardiol Pol; 1985; 28(5):334-9. PubMed ID: 2864465 [No Abstract] [Full Text] [Related]
51. Antihypertensive treatment and fetal welfare in essential hypertension in pregnancy: a retrospective survey of experience with various regimes at National Women's Hospital, Auckland, 1970-80. Lubbe WF; Hodge JV; Kellaway GS N Z Med J; 1982 Jan; 95(699):1-5. PubMed ID: 6950309 [TBL] [Abstract][Full Text] [Related]
52. Plasma purine turnover metabolites in women with normal pregnancy and pregnancy complicated with induced hypertension as compared to fetal well-being indices. Klejewski A; Szcześniak-Chmielecka A; Zeromska-Cancellaro M; Urbaniak T J Perinat Med; 2000; 28(5):399-406. PubMed ID: 11125931 [TBL] [Abstract][Full Text] [Related]